Cited by

• Direct-acting antiviral treatments display excellent outcomes even in older HCV-infected patients at increased risk of fibrosis.

  Xia H, Zhang Y, Zaongo SD, Liang J, Gong X, Hu Y, Ma P, Wang F. Xia H, et al. Ann Transl Med. 2021 May;9(10):847. doi: 10.21037/atm-21-1297. Ann Transl Med. 2021. PMID: 34164481 Free PMC article.
• Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.

  Lim KB, Sima HR, Fiel MI, Khaitova V, Doucette JT, Chernyiak M, Ahmad J, Bach N, Chang C, Grewal P, Kim-Schluger L, Liu L, Odin J, Perumalswami P, Florman SS, Schiano TD. Lim KB, et al. World J Gastroenterol. 2015 May 28;21(20):6236-45. doi: 10.3748/wjg.v21.i20.6236. World J Gastroenterol. 2015. PMID: 26034358 Free PMC article.
• Telementoring of primary care providers delivering hepatitis C treatment in New York City: Results from Project INSPIRE.

  Teixeira PA, Bresnahan MP, Laraque F, Litwin AH, Shukla SJ, Schwartz JM, Reynoso S, Perumalswami PV, Weiss JM, Wyatt B, Schackman BR. Teixeira PA, et al. Learn Health Syst. 2018 Jul;2(3):e10056. doi: 10.1002/lrh2.10056. Epub 2018 May 10. Learn Health Syst. 2018. PMID: 31106275 Free PMC article.
• The evolution and clinical impact of hepatitis B virus genome diversity.

  Revill PA, Tu T, Netter HJ, Yuen LKW, Locarnini SA, Littlejohn M. Revill PA, et al. Nat Rev Gastroenterol Hepatol. 2020 Oct;17(10):618-634. doi: 10.1038/s41575-020-0296-6. Epub 2020 May 28. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32467580 Review.
• Effect of season and sunlight on viral kinetics during hepatitis C virus therapy.

  Hernández-Alvarez N, Pascasio Acevedo JM, Quintero E, Fernández Vázquez I, García-Eliz M, de la Revilla Negro J, Crespo García J, Hernández-Guerra M. Hernández-Alvarez N, et al. BMJ Open Gastroenterol. 2017 Mar 4;4(1):e000115. doi: 10.1136/bmjgast-2016-000115. eCollection 2017. BMJ Open Gastroenterol. 2017. PMID: 28321328 Free PMC article.